Since CD19 is known to be a B-lymphocyte antigen and CD10 a marker of lymphocytic differentiation, this result suggests that B-ALL arises, as in AML, from a primitive immature cell instead of a committed B cell[34,149]. Here, CD19 is linked to acute myeloid leukemia.